Search Results - "Balykina, Yu E"

Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study by Kolbin, A. S., Gomon, Yu. M., Proskurin, M. A., Balykina, Yu. E.

“…Objective: to evaluate the clinical and economic effectiveness of alectinib in comparison with lorlatinib in adult patients with advanced anaplastic lymphoma…”
Get full text

A Systematic Review with Meta-Analysis and Indirect Comparison of the Effectiveness of COVID-19 Anti-Interleukin Therapy by Yu. M. Gomon, A. S. Kolbin, A. M. Fahrutdinova, T. A. Usmanova, F. M. Sultanova, Yu. E. Balykina

“…Aim. Evaluation of the effectiveness of anti-interleukin drugs used in the pathogenetic therapy of COVID-19 in relation to the relative risks of 28-day…”
Get full text

Pharmacoeconomic analysis of fixed-duration targeted therapy regimens for chronic lymphocytic leukemia compared with therapy used until progression or intolerable toxicity by Kasimova, A. R., Kolbin, A. S., Proskurin, M. A., Balykina, Yu. E.

“…Background. Chronic lymphocytic leukemia (CLL) is a b-cell tumor of small b-lymphocytes. In CLL, significant lymphocytosis (5000 monoclonal b-lymphocytes) is…”
Get full text

Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus by Kolbin, A. S., Kurylev, A. A., Balykina, Yu. E., Proskurin, M. A.

“…Ipragliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduce plasma glucose concentrations by inhibiting glucose reabsorption by…”
Get full text

Efficiency of Levilimab in patients with moderate and severe COVID-19 by Gomon, Yu. M., Strizheletsky, V. V., Ivanov, I. G., Balykina, Yu. E., Ermolyev, M. V., Kolbin, A.  S., Livshits, M. V., Usmanova, T.  A., Fakhrutdinova, A. M., Konstantinova, Yu. S. , Gubanov, A. P.

“…Objective: evaluation of the clinical and economic efficiency of using Levilimab in the treatment of moderate and severe COVID-19 based on real world data…”
Get full text

Socioeconomic and global burden of COVID-19 by Kolbin, A. S., Gomon, Yu. M., Balykina, Yu. E., Belousov, D. Yu, Strizheletskiy, V. V., Ivanov, I. G.

“…Relevance . Assessment of the burden of disease provides information on the economic consequences of the disease, allows you to assess the social significance,…”
Get full text

Cystic fibrosis as a social-economic burden by Kolbin, A. S., Gomon, Yu. M., Karpov, O. I., Balykina, Yu. E., Proskurin, M. A.

“…Cystic fibrosis (CF) is a chronic genetic disease with social significant weight because it influences on social humanitarian part of health and on sources of…”
Get full text

A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption by Arepyeva, M.A., Kolbin, A.S., Sidorenko, S.V., Lawson, R., Kurylev, A.A., Balykina, Yu E., Mukhina, N.V., Spiridonova, A.A.

“…•Inclusion of antibiotic consumption in the model improves the forecast accuracy.•Consumption of inhibitor/cephalosporins increases inhibitor/penicillin…”
Get full text

Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis by Kolbin, A. S., Kurylev, A. A., Mishinova, S. A., Balykina, Yu. E., Proskurin, M. A.

“…Rationale. Rheumatoid arthritis (RA) and systemic juvenile arthritis (sJA) are the most frequent rheumatic diseases in adults and adolescents, consequently…”
Get full text

Socio-economic burden of COVID-19 in the Russian Federation by Kolbin, A. S., Belousov, D. Yu, Gomon, Yu. M., Balykina, Yu. E., Ivanov, I. G.

“…Purpose. Assessment of the socio-economic burden of COVID-19 in the Russian Federation (RF). Materials and methods. Identification and assessment of direct…”
Get full text

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia by Vilyum, I. A., Andreev, B. V., Proskurin, M. A., Balykina, Yu. E.

“…The aim: to provide a comprehensive pharmacoeconomic evaluation of the maintenance therapy with antipsychotics in outpatients diagnosed with schizophrenia…”
Get full text

Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma by Kolbin, A S, Avdeev, S N, Zhuravleva, M V, Gomon, Yu M, Balykina, Yu E, Matveyev, N V, Proskurin, M A, Fedosenko, S V

“…Asthma is a heterogeneous chronic disease of airways. One of its endotypes is eosinophilic asthma, accompanied by both peripheral blood and airway…”
Get full text

PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS by Kolbin, A. S., Vilum, I. A., Proskurin, М. A., Balykina, Yu. E.

“…Objectives. To provide a pharmacoeconomic analysis of brentuximab vetodin therapy in relapsed or refractory CD30+ systemic anaplastic large-cell lymphoma in…”
Get full text

HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE by Kolbin, A. S., Kurylev, A. A., Proskurin, M. A., Balykina, Yu. E.

“…Objective. To perform health economic evaluation of several antirheumatic drugs in patients with rheumatoid arthritis (RA) progressed after DMARDs.Materials…”
Get full text

Pharmacoeconomic analysis of using mirabegron to treat overactive bladder in the setting of the Russian Federation health care by Kolbin, A S, Vilyum, I A, Proskurin, M A, Balykina, Yu E

“…The present paper presents, for the first time in Russia, a comparative pharmacoeconomic analysis of using mirabegron (Betmiga) to treat overactive bladder…”
Get more information

Modeling microbial drug-resistance: from mathematics to pharmacoeconomics by Gomon, Yu. M., Arepyeva, M. A., Balykina, Yu. E., Kolbin, A. S., Kurylev, A. A., Proskurin, M. A., Sidorenko, S. V.

“…Complicated intra-abdominal infection (IAI) requires increased health care expenditures and additional resources to compensate for an ineffective starting…”
Get full text

PROBLEMS OF COMPLICATED INTRA-ABDOMINAL INFECTION’S ANTIBACTERIAL TREATMENT IN MULTIDISCIPLINARY HOSPITALS by Gomon, Yu. M., Kolbin, A. S., Balykina, Yu. E., Arepyeva, M. A., Sidorenko, S. V., Strizheletskiy, V. V., Ivanov, I. G., Lobzin, Yu. V., Grinenko, О. A.

“…The objective is to assess the economic efficiency of the current practice of complicated IAI (intra-abdominal infections) treatment with antibiotics compared…”
Get full text

ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS) by Gomon, Yu. M., Kolbin, A. S., Sidorenko, S. V., Kuzhel’, A. M., Repina, A. V., Lobzin, Yu. V., Balykina, Yu. E.

“…A survey conducted in four hospitals located in the city of St. Petersburg revealed that the commonly used perioperative antibiotic prophylaxis (PAP) did not…”
Get full text

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 by Kolbin, A. S., Prasolov, A. V., Maksimkina, E. A., Balykina, Yu. E., Golant, Z. M., Polushin, Yu. S., Kurylev, A. A., Vilyum, I. A.

“…Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug inclusion and exclusion into the reimbursement lists in…”
Get full text

HARPER — protocol template for real-world trials for evaluating treatment efficacy by S. M. Mukhina, M. I. Baranova, Yu. E. Balykina

“…The International Society of Pharmacoepidemiology (ISPE) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) have created a joint…”
Get full text